Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

• Sakib Burza ,

  * E-mail: sakibburza@gmail.com

  Affiliation Médecins Sans Frontières, New Delhi, India

  ⨯
• Prabhat K. Sinha,

  Affiliation Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar, India

  ⨯
• Raman Mahajan,

  Affiliation Médecins Sans Frontières, New Delhi, India

  ⨯
• María Angeles Lima,

  Affiliation Médecins Sans Frontières, Barcelona, Spain

  ⨯
• Gaurab Mitra,

  Affiliation Médecins Sans Frontières, New Delhi, India

  ⨯
• Neena Verma,

  Affiliation Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar, India

  ⨯
• Manica Balsegaram,

  Affiliation ACCESS Campaign, Geneva, Switzerland

  ⨯
• Pradeep Das

  Affiliation Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar, India

  ⨯